Researching Modifiable and Non-Modifiable Risk Factors Linked to Cognitive Resilience in Alzheimer’s Disease
What do we do?
Our lab focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a pernicious trajectory that culminates in Alzheimer’s dementia. In this context, we are particularly interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors. Overlaid on this research agenda are investigations of health accessibility, and how such accessibility exacerbates or ameliorates the impact of biomarkers on clinical phenotypes.
We use many techniques in our research, including but not limited to:
This is an accordion element with a series of buttons that open and close related content panels.
MRI and PET Imaging


Cerebrospinal Fluid Collection

Maximal Exercise Testing


Blood-based Biomarkers

Physical Activity Monitoring

Cognitive Testing

We are a part of the larger Wisconsin Alzheimer’s Disease Research Program, which includes both the Wisconsin Alzheimer’s Disease Research Center and the Wisconsin Alzheimer’s Institute.
Our offices are located on UW Madison’s campus within the UW Hospital and WARF. The majority of our research is conducted at the UW Hospital, the Waisman Center, the Wisconsin Institute for Medical Research, and the YMCA.
News Highlights

Asha Coy Accepted Into Medical School
Asha Coy was accepted into the Marian University College of Osteopathic Medicine in Indianapolis. She will start this August, and we couldn’t be more excited for her. Congratulations, Asha – we are beyond proud of …
June 12, 2026
Sara Fernandes-Taylor’s Manuscript Accepted for Publication
Sara Fernandes-Taylor’s manuscript “Neurodegeneration, neuroinflammation, and synaptic dysfunction biomarkers in cognitively unimpaired people with advanced Alzheimer pathology” has been accepted for publication in Neurology Open Access. Congratulations, SFT!
June 8, 2026
Gabriella Mamlouk Awarded The Graduate School’s Student Research Grants Competition Fellowship
Gabriella Mamlouk was awarded The Graduate School’s Student Research Grants Competition Fellowship! This fellowship provides funding support for graduate students to present their research at conferences. Congratulations, Gabby! We are so excited to have you …
June 3, 2026Abstracts Accepted for Poster Presentations at AAIC 2026
The Okonkwo Lab has four lab members whose abstracts were accepted for poster presentations at AAIC 2026 in London, England: Gabriella Mamlouk: Racial Identity Moderates the Association Between Depression And AD-Relevant Plasma Biomarkers in a …
May 28, 2026- More News





